Which systemic therapy in concurrent chemoradiotherapy?

Date 07 October 2016
Event ESMO 2016 Congress
Session Optimal treatment of stage III NSCLC
Topics Cytotoxic agents
Surgical oncology
Non-small-cell lung cancer
Therapy
Biological therapy
Radiation oncology
Presenter Johan Vansteenkiste
Authors J.F. Vansteenkiste
  • Respiratory Oncology Unit - Department Respiratory Diseases, University Hospitals KU Leuven, 3000 - Leuven/BE